Fulgent Genetics, Inc.

Historical 13F Holders

Symbol
FLGT
CUSIP
359664109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 359664109 since 12/18/2024, newest first.

Filer % of Class Filed
Ming Hsieh 13D/A Amendment 5
32.3% 5/27/2026
Event 5/22/2026
Ming Hsieh 13D/A Amendment 4
30.7% 3/31/2026
Event 3/19/2026
Millennium Management LLC 13G/A Amendment 4
3.0% 2/4/2026
Event 12/31/2025
Millennium Management LLC 13G/A Amendment 3
5.6% 7/29/2025
Event 7/22/2025
Millennium Management LLC 13G/A Amendment 2
4.7% 7/29/2025
Event 6/30/2025
Barclays PLC 13G/A Amendment 2 7.6% 5/13/2025
Event 3/31/2025
Millennium Management LLC 13G/A Amendment 1
6.5% 5/6/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 3 5.9% 4/3/2025
Event 3/31/2025
Barclays PLC 13G/A Amendment 1 5.4% 3/21/2025
Event 12/31/2024
Barclays PLC 13G 5.4% 2/7/2025
Event 12/31/2024
Millennium Management LLC 13G
5.0% 1/8/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 19 343 k $7.55 M
2026 Q2 145 15.7 M $322 M
2026 Q1 162 17.5 M $278 M
2025 Q4 185 17.9 M $470 M
2025 Q3 170 17.5 M $397 M
2025 Q2 175 16.7 M $333 M
2025 Q1 184 16.3 M $276 M
2024 Q4 197 17.0 M $314 M
2024 Q3 191 16.4 M $357 M
2024 Q2 187 15.8 M $310 M
2024 Q1 197 15.5 M $338 M
2023 Q4 212 15.0 M $434 M
2023 Q3 213 14.2 M $381 M
2023 Q2 228 13.9 M $515 M
2023 Q1 234 13.6 M $424 M
2022 Q4 240 14.0 M $416 M
2022 Q3 254 13.4 M $509 M
2022 Q2 283 13.0 M $711 M
2022 Q1 300 12.4 M $764 M
2021 Q4 325 11.3 M $1.14 B
2021 Q3 288 11.4 M $1.02 B
2021 Q2 282 10.7 M $987 M
2021 Q1 282 10.1 M $974 M
2020 Q4 220 9.96 M $521 M
2020 Q3 136 8.09 M $324 M
2020 Q2 87 6.54 M $106 M
2020 Q1 76 6.11 M $65.7 M
2019 Q4 75 5.76 M $74.5 M
2019 Q3 36 2.93 M $30.6 M
2019 Q2 15 1.30 M $8.85 M
2019 Q1 17 1.24 M $7.55 M
2018 Q4 17 1.29 M $4.10 M
2018 Q3 18 1.46 M $5.73 M
2018 Q2 16 1.45 M $6.01 M
2018 Q1 21 1.45 M $5.79 M
2017 Q4 18 1.42 M $6.20 M
2017 Q3 21 2.39 M $11.4 M
2017 Q2 22 2.98 M $19.0 M
2017 Q1 38 3.50 M $38.2 M
2016 Q4 38 3.08 M $35.6 M
2016 Q3 16 2.65 M $24.4 M